Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (171-180 of 469) with videos related to

Pageof 47
Sort By:
Journal of Digital Imaging|September 22, 2023
External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung CancerAshish Kumar Jha, Umeshkumar B Sherkhane, Sneha Mthun, et al.
Radiation Oncology (London, England)|September 17, 2020
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trialTejpal Gupta, Shwetabh Sinha, Sarbani Ghosh-Laskar, et al.
BMJ Open|February 16, 2021
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancerAnil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|January 27, 2016
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care centerAvinash Vijaykumar Pandey, Deepa Susan Phillip, Vanita Noronha, et al.
Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.
South Asian Journal of Cancer|November 16, 2018
Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysisVivek Agarwala, Anant Ramaswamy, Amit Joshi, et al.
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Frontiers in Oncology|March 9, 2019
Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck CancerPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up studySachin Punatar, Shruti Kandekar, Navin Khattry, et al.
Pageof 47

Showing results (171-180 of 469) with videos related to

Sort By:
Pageof 47
Journal of Digital Imaging|September 22, 2023
External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung CancerAshish Kumar Jha, Umeshkumar B Sherkhane, Sneha Mthun, et al.
Radiation Oncology (London, England)|September 17, 2020
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trialTejpal Gupta, Shwetabh Sinha, Sarbani Ghosh-Laskar, et al.
BMJ Open|February 16, 2021
Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancerAnil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|January 27, 2016
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care centerAvinash Vijaykumar Pandey, Deepa Susan Phillip, Vanita Noronha, et al.
Lung Cancer (Auckland, N.Z.)|February 19, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisShruti Kate, Anuradha Chougule, Amit Joshi, et al.
South Asian Journal of Cancer|November 16, 2018
Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysisVivek Agarwala, Anant Ramaswamy, Amit Joshi, et al.
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Frontiers in Oncology|March 9, 2019
Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck CancerPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up studySachin Punatar, Shruti Kandekar, Navin Khattry, et al.
Pageof 47